In Accordance with code of Internal Procedure and Conduct of Regulating, Monitoring and Reporting of Trading by Employee and other connected person of the Company framed pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading ) Regulation, 2015 read with BSE Circular Ref. No. List/COMP//01/2019-20 dated 24 April, 2019, Chandra Bhagat Pharma has informed that the trading window for dealing in the securities of the company will be closed for all directors, officers and KMP (key managerial personal), designated employee of the company with immediate effect and would open 48 hours after the announcement of Financial Result for the half year ended on 30th September, 2021.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1847.30 |
| Dr. Reddys Lab | 1293.25 |
| Cipla | 1347.70 |
| Zydus Lifesciences | 938.90 |
| Lupin | 2377.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: